Arif on Media' can be read here. Click here to read Arif's most recent stories for Media Week and Campaign. Mark Frith is making a return to magazines as editor-in-chief of Now, Time Inc's celebrity ...

The latest installment in BioPharma Dive’s new visualization-focused series features a stock sell-off that confused Wall ...

Haleon's dual-placement strategy for Advil and TUMS at CVS lifted first-quarter sales per store, and talks with Walmart are ...

FDA approved KERENDIA (finerenone) as the first new treatment in 30 years for adults with chronic kidney disease associated ...

Tempus AI (TEM) stock surged 15% Thursday as CEO outlined up to $400M in Medicare revenue. TEM is up 92% from its July low.

Tempus AI (TEM) stock jumped 15% Thursday after CEO outlined Medicare revenue expectations up to $400M. Shares have surged 92% since July bottom.

GSK slides 1.82% today to GBX1865.50 despite ongoing progress in oncology and vaccines, with volatility remaining elevated.

Tempus AI shares pulled back Friday after a five-day rally of nearly 40% driven by CEO Eric Lefkofsky's reimbursement projections at the ...

The life sciences industry is entering a period in which artificial intelligence is increasingly becoming part of how ...

Tempus AI (TEM) stock jumped 15% Thursday after CEO projected up to $400M in Medicare revenue. The stock has rallied 92% since its July low of $41.55.

A global coalition of patient advocates, industry and non-profit organisations has called on governments to strengthen action on chronic obstructive pulmonary ...